Ketamine and Spravato providers: official registers and how to verify one
We list ketamine and Spravato providers only from an official register. On 26 Oct 2026 no US state published one. Texas and Georgia are setting registers up, and we check both every week. Until then, this page shows how to verify a provider yourself.
No clinic pays to appear here, and none ever will: Peyote.com takes no commission, featured fee or referral payment from any US clinic (why).
Status:Proposed, not adopted. First proposed in January 2026, adopted and then rescinded in spring 2026, and re-proposed in the Texas Register of 10 July 2026; the Board says a public hearing will be held at a later date. No register exists yet, and the proposal does not say whether the list of registered practices will be public.
Register expected:180 days after the Board adopts the rule, if it does
Georgia: Georgia Composite Medical Board
HB 717 (2026) added O.C.G.A. 43-34-49: from 1 July 2027 every clinic offering psychedelic-assisted treatment, including intravenous ketamine, must hold a licence from the Georgia Composite Medical Board, renewed every two years, one per location; running an unlicensed clinic is a felony. The Board must adopt rules by 31 December 2026. The law excludes hospital-affiliated clinics and FDA-approved drugs used on label, so Spravato given on label may fall outside it. (Georgia General Assembly, HB 717 (2025-2026 session), as passed; Georgia Composite Medical Board, licence verification)
Status:Law in force since 1 July 2026; licensing starts 1 July 2027. No rules or list published yet.
Register expected:1 July 2027
Spravato: checking a certified setting
Spravato (esketamine) nasal spray can only be given in a healthcare setting certified under its REMS, the FDA's restricted programme, with monitoring for at least two hours after each dose. (FDA, approved REMS: Spravato (esketamine), NDA 211243) The REMS publishes no list or search of certified settings. To check one, call the Spravato REMS on 1-855-382-6022 and ask whether the setting is certified. (Spravato REMS (the programme's own site))
The manufacturer runs a treatment centre locator. It is the manufacturer's tool, not a regulator's, and its terms allow personal, non-commercial use only, so we link to it rather than copy it.
FDA approvals (NDA 211243): Treatment-resistant depression in adults, with an oral antidepressant, 5 Mar 2019 (approval letter); Depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behaviour, 31 Jul 2020 (approval letter); Treatment-resistant depression in adults, on its own (monotherapy), 17 Jan 2025 (approval letter).
Ketamine is prescribed off label by a licensed clinician. Ask who the prescribing physician is, then look them up on the state board's own site: the licence should be active, in the state where you are treated, with any discipline shown. DocInfo, run by the Federation of State Medical Boards, searches every state at once.
Twenty state boards and the national search; links checked 26 Oct 2026. For any other state, use DocInfo or search for that state's medical board.
The dispatch
Laws change. Centres change. Know before you book.
A brief, sent only in weeks when something changes: jurisdictions that shifted, listings added or revised, and the research worth reading. No hype, no sourcing talk.
Educational only. Not medical advice. Unsubscribe any time.